Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 5.75741506 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.75741506 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.15415707 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.15415707 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.05152765 |
6 | bile acid biosynthetic process (GO:0006699) | 4.54924611 |
7 | indole-containing compound catabolic process (GO:0042436) | 4.49090781 |
8 | indolalkylamine catabolic process (GO:0046218) | 4.49090781 |
9 | tryptophan catabolic process (GO:0006569) | 4.49090781 |
10 | oligosaccharide catabolic process (GO:0009313) | 4.47379798 |
11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36958452 |
12 | tryptophan metabolic process (GO:0006568) | 4.20473379 |
13 | cellular response to vitamin D (GO:0071305) | 4.17691588 |
14 | aldehyde catabolic process (GO:0046185) | 4.07073961 |
15 | glycosphingolipid catabolic process (GO:0046479) | 4.05917598 |
16 | regulation of mononuclear cell migration (GO:0071675) | 4.04326267 |
17 | cellular response to vitamin (GO:0071295) | 3.81741692 |
18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.75105272 |
19 | glycolipid catabolic process (GO:0019377) | 3.67430583 |
20 | aromatic amino acid family metabolic process (GO:0009072) | 3.64399776 |
21 | glyoxylate metabolic process (GO:0046487) | 3.62789328 |
22 | kynurenine metabolic process (GO:0070189) | 3.62169645 |
23 | cell adhesion mediated by integrin (GO:0033627) | 3.59495647 |
24 | bile acid metabolic process (GO:0008206) | 3.58320844 |
25 | regulation of cholesterol esterification (GO:0010872) | 3.54848825 |
26 | amine catabolic process (GO:0009310) | 3.48901110 |
27 | cellular biogenic amine catabolic process (GO:0042402) | 3.48901110 |
28 | keratan sulfate catabolic process (GO:0042340) | 3.48645237 |
29 | adhesion of symbiont to host cell (GO:0044650) | 3.48623184 |
30 | virion attachment to host cell (GO:0019062) | 3.48623184 |
31 | cysteine metabolic process (GO:0006534) | 3.46327071 |
32 | skin morphogenesis (GO:0043589) | 3.39825042 |
33 | tyrosine metabolic process (GO:0006570) | 3.39590243 |
34 | ceramide catabolic process (GO:0046514) | 3.37329841 |
35 | peroxisome fission (GO:0016559) | 3.35827735 |
36 | protein localization to endosome (GO:0036010) | 3.31051753 |
37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30108620 |
38 | response to lipoprotein particle (GO:0055094) | 3.27614756 |
39 | indolalkylamine metabolic process (GO:0006586) | 3.27605248 |
40 | drug transmembrane transport (GO:0006855) | 3.24654005 |
41 | response to hepatocyte growth factor (GO:0035728) | 3.21443517 |
42 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.21443517 |
43 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.20272295 |
44 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.19338544 |
45 | macroautophagy (GO:0016236) | 3.18847994 |
46 | response to vitamin D (GO:0033280) | 3.18112233 |
47 | eosinophil chemotaxis (GO:0048245) | 3.15409984 |
48 | positive regulation of calcium ion import (GO:0090280) | 3.12509724 |
49 | cellular ketone body metabolic process (GO:0046950) | 3.12454451 |
50 | homocysteine metabolic process (GO:0050667) | 3.12319954 |
51 | urate metabolic process (GO:0046415) | 3.09820864 |
52 | opsonization (GO:0008228) | 3.09689832 |
53 | central nervous system myelination (GO:0022010) | 3.04151419 |
54 | axon ensheathment in central nervous system (GO:0032291) | 3.04151419 |
55 | regulation of metalloenzyme activity (GO:0048552) | 3.02794959 |
56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02273611 |
57 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.02271564 |
58 | regulation of protein activation cascade (GO:2000257) | 3.00661300 |
59 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.99590863 |
60 | uronic acid metabolic process (GO:0006063) | 2.98964413 |
61 | glucuronate metabolic process (GO:0019585) | 2.98964413 |
62 | low-density lipoprotein particle remodeling (GO:0034374) | 2.98379386 |
63 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.97669443 |
64 | coenzyme catabolic process (GO:0009109) | 2.97125856 |
65 | short-chain fatty acid metabolic process (GO:0046459) | 2.95917222 |
66 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.94341705 |
67 | protein carboxylation (GO:0018214) | 2.94341705 |
68 | alpha-amino acid catabolic process (GO:1901606) | 2.93526811 |
69 | membrane lipid catabolic process (GO:0046466) | 2.92603638 |
70 | apoptotic cell clearance (GO:0043277) | 2.92571843 |
71 | adhesion of symbiont to host (GO:0044406) | 2.91474413 |
72 | sphingolipid catabolic process (GO:0030149) | 2.90207036 |
73 | protein-lipid complex remodeling (GO:0034368) | 2.89622982 |
74 | macromolecular complex remodeling (GO:0034367) | 2.89622982 |
75 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89622982 |
76 | regulation of fibrinolysis (GO:0051917) | 2.88609769 |
77 | negative regulation of protein activation cascade (GO:2000258) | 2.87457987 |
78 | fatty acid elongation (GO:0030497) | 2.87186074 |
79 | Golgi transport vesicle coating (GO:0048200) | 2.86214487 |
80 | COPI coating of Golgi vesicle (GO:0048205) | 2.86214487 |
81 | sphingosine metabolic process (GO:0006670) | 2.84584356 |
82 | barbed-end actin filament capping (GO:0051016) | 2.84544198 |
83 | regulation of complement activation (GO:0030449) | 2.84391292 |
84 | regulation of macrophage chemotaxis (GO:0010758) | 2.84361592 |
85 | phospholipid efflux (GO:0033700) | 2.83494077 |
86 | cholesterol efflux (GO:0033344) | 2.82427753 |
87 | drug catabolic process (GO:0042737) | 2.81725716 |
88 | very long-chain fatty acid metabolic process (GO:0000038) | 2.79537061 |
89 | peptide catabolic process (GO:0043171) | 2.78808105 |
90 | eosinophil migration (GO:0072677) | 2.76666883 |
91 | complement activation, alternative pathway (GO:0006957) | 2.75431688 |
92 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.75369710 |
93 | angiotensin maturation (GO:0002003) | 2.74711471 |
94 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.74509550 |
95 | cofactor catabolic process (GO:0051187) | 2.74267689 |
96 | amino-acid betaine metabolic process (GO:0006577) | 2.74015855 |
97 | NAD biosynthetic process (GO:0009435) | 2.72767123 |
98 | dicarboxylic acid catabolic process (GO:0043649) | 2.72428672 |
99 | sulfur amino acid catabolic process (GO:0000098) | 2.71242754 |
100 | ketone body metabolic process (GO:1902224) | 2.70434106 |
101 | reverse cholesterol transport (GO:0043691) | 2.70420983 |
102 | amino sugar catabolic process (GO:0046348) | 2.70416022 |
103 | cellular amino acid catabolic process (GO:0009063) | 2.69436058 |
104 | indole-containing compound metabolic process (GO:0042430) | 2.69337280 |
105 | drug transport (GO:0015893) | 2.69302142 |
106 | L-ascorbic acid metabolic process (GO:0019852) | 2.69274501 |
107 | nitrogen cycle metabolic process (GO:0071941) | 2.68105242 |
108 | glutamate metabolic process (GO:0006536) | 2.68044207 |
109 | urea cycle (GO:0000050) | 2.67228833 |
110 | urea metabolic process (GO:0019627) | 2.67228833 |
111 | serine family amino acid catabolic process (GO:0009071) | 2.66546416 |
112 | glutathione biosynthetic process (GO:0006750) | 2.65496386 |
113 | cellular glucuronidation (GO:0052695) | 2.65271726 |
114 | fibrinolysis (GO:0042730) | 2.65247470 |
115 | negative regulation of complement activation (GO:0045916) | 2.64715894 |
116 | bile acid and bile salt transport (GO:0015721) | 2.64245825 |
117 | exogenous drug catabolic process (GO:0042738) | 2.61600749 |
118 | cellular modified amino acid catabolic process (GO:0042219) | 2.61202107 |
119 | blood coagulation, intrinsic pathway (GO:0007597) | 2.59488418 |
120 | carboxylic acid catabolic process (GO:0046395) | 2.59269221 |
121 | organic acid catabolic process (GO:0016054) | 2.59269221 |
122 | response to parathyroid hormone (GO:0071107) | 2.58090510 |
123 | negative regulation of lipase activity (GO:0060192) | 2.57463108 |
124 | monocarboxylic acid catabolic process (GO:0072329) | 2.55205605 |
125 | cellular response to nutrient (GO:0031670) | 2.54372121 |
126 | nucleotide transmembrane transport (GO:1901679) | 2.54264113 |
127 | benzene-containing compound metabolic process (GO:0042537) | 2.52693637 |
128 | lipid oxidation (GO:0034440) | 2.52181069 |
129 | fatty acid oxidation (GO:0019395) | 2.51877287 |
130 | glycoside metabolic process (GO:0016137) | 2.51575042 |
131 | flavonoid metabolic process (GO:0009812) | 2.50238252 |
132 | fatty acid catabolic process (GO:0009062) | 2.49876053 |
133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.49222798 |
134 | regulation of cholesterol homeostasis (GO:2000188) | 2.48803415 |
135 | amyloid precursor protein catabolic process (GO:0042987) | 2.47489454 |
136 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.47287864 |
137 | negative regulation of coagulation (GO:0050819) | 2.45714914 |
138 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.45550031 |
139 | lytic vacuole organization (GO:0080171) | 2.44592595 |
140 | lysosome organization (GO:0007040) | 2.44592595 |
141 | transcytosis (GO:0045056) | 2.44425537 |
142 | fatty acid beta-oxidation (GO:0006635) | 2.43229744 |
143 | response to thyroid hormone (GO:0097066) | 2.43052554 |
144 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.42804139 |
145 | transferrin transport (GO:0033572) | 2.41996473 |
146 | negative regulation of fibrinolysis (GO:0051918) | 2.41869543 |
147 | protein activation cascade (GO:0072376) | 2.41732936 |
148 | triglyceride homeostasis (GO:0070328) | 2.41002109 |
149 | acylglycerol homeostasis (GO:0055090) | 2.41002109 |
150 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.40544014 |
151 | positive regulation of extracellular matrix organization (GO:1903055) | 2.40492423 |
152 | negative regulation of wound healing (GO:0061045) | 2.39848514 |
153 | diol metabolic process (GO:0034311) | 2.39671151 |
154 | COPII vesicle coating (GO:0048208) | 2.38144868 |
155 | substrate-dependent cell migration (GO:0006929) | 2.37263912 |
156 | regulation of triglyceride catabolic process (GO:0010896) | 2.36589191 |
157 | regulation of cholesterol storage (GO:0010885) | 2.36317595 |
158 | extracellular negative regulation of signal transduction (GO:1900116) | 2.36261823 |
159 | extracellular regulation of signal transduction (GO:1900115) | 2.36261823 |
160 | plasma lipoprotein particle clearance (GO:0034381) | 2.36015067 |
161 | vasodilation (GO:0042311) | 2.35719924 |
162 | response to phenylpropanoid (GO:0080184) | 2.35668832 |
163 | iron ion import (GO:0097286) | 2.35225205 |
164 | bone resorption (GO:0045453) | 2.34911962 |
165 | sphingoid metabolic process (GO:0046519) | 2.34763824 |
166 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.34652279 |
167 | N-acetylneuraminate metabolic process (GO:0006054) | 2.34096300 |
168 | negative regulation of hemostasis (GO:1900047) | 2.33902772 |
169 | negative regulation of blood coagulation (GO:0030195) | 2.33902772 |
170 | endosome to pigment granule transport (GO:0043485) | 2.32944906 |
171 | endosome to melanosome transport (GO:0035646) | 2.32944906 |
172 | decidualization (GO:0046697) | 2.31279184 |
173 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.30664131 |
174 | protein maturation by protein folding (GO:0022417) | 2.29881178 |
175 | membrane raft organization (GO:0031579) | 2.29772586 |
176 | positive regulation of leukocyte degranulation (GO:0043302) | 2.28920887 |
177 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28036844 |
178 | regulation of extracellular matrix disassembly (GO:0010715) | 2.26553564 |
179 | ferric iron transport (GO:0015682) | 2.25457313 |
180 | trivalent inorganic cation transport (GO:0072512) | 2.25457313 |
181 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.23873114 |
182 | hyaluronan catabolic process (GO:0030214) | 2.22667431 |
183 | viral entry into host cell (GO:0046718) | 2.22587168 |
184 | nitric oxide biosynthetic process (GO:0006809) | 2.22504756 |
185 | xenobiotic catabolic process (GO:0042178) | 2.20791546 |
186 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.20719454 |
187 | response to lead ion (GO:0010288) | 2.20176206 |
188 | regulation of collagen metabolic process (GO:0010712) | 2.19376658 |
189 | sphingomyelin metabolic process (GO:0006684) | 2.18937006 |
190 | intracellular pH reduction (GO:0051452) | 2.16992280 |
191 | positive regulation of coagulation (GO:0050820) | 2.15439068 |
192 | endodermal cell differentiation (GO:0035987) | 2.14495708 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.63477189 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.18090336 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15037932 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.79596876 |
5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.79537236 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.58724198 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51687810 |
8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.47029514 |
9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.34328895 |
10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.23355021 |
11 | CJUN_26792858_Chip-Seq_BT549_Human | 2.22297209 |
12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20909739 |
13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19479308 |
14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16363002 |
15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.11182211 |
16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.10097064 |
17 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.06170498 |
18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04795242 |
19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01172288 |
20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99912587 |
21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94284731 |
22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92470255 |
23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87212380 |
24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86697567 |
25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85202733 |
26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.84824926 |
27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84646128 |
28 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81748363 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81060316 |
30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.79454981 |
31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78861768 |
32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76915433 |
33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76253354 |
34 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73609727 |
35 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.72546139 |
36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.72477293 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69933830 |
38 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69292509 |
39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.68539811 |
40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68197856 |
41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67437825 |
42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67433989 |
43 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67228653 |
44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66786028 |
45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65716339 |
46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.65504162 |
47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62423861 |
48 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61572426 |
49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58975427 |
50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58058125 |
51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57845216 |
52 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57690496 |
53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57529654 |
54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57243346 |
55 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57238387 |
56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56977936 |
57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56652379 |
58 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55839225 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53133127 |
60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51714631 |
61 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49849748 |
62 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49849748 |
63 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48795044 |
64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.48693767 |
65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47140975 |
66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46889625 |
67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45484677 |
68 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.44657509 |
69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43966458 |
70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43628556 |
71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43564131 |
72 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.43173220 |
73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42443547 |
74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42379583 |
75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42379583 |
76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42149608 |
77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41307491 |
78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41307491 |
79 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38669455 |
80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38662278 |
81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38326053 |
82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36850328 |
83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35671376 |
84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34864248 |
85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34166036 |
86 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33152201 |
87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32324512 |
88 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32235366 |
89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31712913 |
90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31434262 |
91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31196416 |
92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.30903406 |
93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29663307 |
94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27937008 |
95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27330416 |
96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25434436 |
97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24442482 |
98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24374068 |
99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24076450 |
100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22416677 |
101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21687360 |
102 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21274829 |
103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20565157 |
104 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.20060645 |
105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19990530 |
106 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19900963 |
107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19867193 |
108 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.19043564 |
109 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18766471 |
110 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.18578183 |
111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17996917 |
112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17648245 |
113 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17531836 |
114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17113664 |
115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15511174 |
116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14981614 |
117 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.14674793 |
118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14056019 |
119 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13816068 |
120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13479858 |
121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13419013 |
122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12916642 |
123 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12428160 |
124 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10967562 |
125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10263720 |
126 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.10128365 |
127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09980603 |
128 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09744957 |
129 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09329784 |
130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09244902 |
131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08216064 |
132 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08181654 |
133 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.07591005 |
134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05385060 |
135 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04923139 |
136 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03795024 |
137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03749286 |
138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03749286 |
139 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02941020 |
140 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02871158 |
141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02238472 |
142 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.01825501 |
143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00988684 |
144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00978119 |
145 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.00940060 |
146 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00427013 |
147 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00223093 |
148 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98371425 |
149 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.98253593 |
150 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97467082 |
151 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97188714 |
152 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96343657 |
153 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.96287844 |
154 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95988948 |
155 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95947332 |
156 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95728615 |
157 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93467038 |
158 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91352537 |
159 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91311026 |
160 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89134356 |
161 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89070823 |
162 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88151293 |
163 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87446844 |
164 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.86744562 |
165 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.86142293 |
166 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84242022 |
167 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83479847 |
168 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81460840 |
169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81229087 |
170 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80551557 |
171 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.80387314 |
172 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79048584 |
173 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.78747291 |
174 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78622343 |
175 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77972608 |
176 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77277463 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 5.24040691 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.92790284 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.84997850 |
4 | MP0005365_abnormal_bile_salt | 3.73270953 |
5 | MP0008438_abnormal_cutaneous_collagen | 3.47144887 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.43996654 |
7 | MP0000678_abnormal_parathyroid_gland | 3.19374536 |
8 | MP0003195_calcinosis | 3.10450620 |
9 | MP0003880_abnormal_central_pattern | 2.74481914 |
10 | MP0006054_spinal_hemorrhage | 2.67257199 |
11 | MP0005332_abnormal_amino_acid | 2.58498390 |
12 | MP0005083_abnormal_biliary_tract | 2.58136920 |
13 | MP0003950_abnormal_plasma_membrane | 2.44065698 |
14 | MP0004272_abnormal_basement_membrane | 2.41954353 |
15 | MP0005257_abnormal_intraocular_pressure | 2.38680151 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.29774015 |
17 | MP0002876_abnormal_thyroid_physiology | 2.19961459 |
18 | MP0000343_altered_response_to | 2.04314362 |
19 | MP0001666_abnormal_nutrient_absorption | 2.03111662 |
20 | MP0006276_abnormal_autonomic_nervous | 1.91851085 |
21 | MP0000516_abnormal_urinary_system | 1.88164742 |
22 | MP0005367_renal/urinary_system_phenotyp | 1.88164742 |
23 | MP0003252_abnormal_bile_duct | 1.87176078 |
24 | MP0002877_abnormal_melanocyte_morpholog | 1.83725858 |
25 | MP0005451_abnormal_body_composition | 1.79427535 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.79039781 |
27 | MP0010329_abnormal_lipoprotein_level | 1.77986636 |
28 | MP0005058_abnormal_lysosome_morphology | 1.76714240 |
29 | MP0009840_abnormal_foam_cell | 1.73918655 |
30 | MP0002896_abnormal_bone_mineralization | 1.69138745 |
31 | MP0000604_amyloidosis | 1.66228631 |
32 | MP0001958_emphysema | 1.64982940 |
33 | MP0003279_aneurysm | 1.63457252 |
34 | MP0000566_synostosis | 1.62458541 |
35 | MP0002736_abnormal_nociception_after | 1.62292281 |
36 | MP0002254_reproductive_system_inflammat | 1.62180359 |
37 | MP0003300_gastrointestinal_ulcer | 1.60915395 |
38 | MP0005464_abnormal_platelet_physiology | 1.60749531 |
39 | MP0008004_abnormal_stomach_pH | 1.58453776 |
40 | MP0009697_abnormal_copulation | 1.56940895 |
41 | MP0005165_increased_susceptibility_to | 1.55684432 |
42 | MP0005084_abnormal_gallbladder_morpholo | 1.55395624 |
43 | MP0002735_abnormal_chemical_nociception | 1.54973517 |
44 | MP0003566_abnormal_cell_adhesion | 1.51137449 |
45 | MP0003191_abnormal_cellular_cholesterol | 1.47931591 |
46 | MP0010386_abnormal_urinary_bladder | 1.47684606 |
47 | MP0001968_abnormal_touch/_nociception | 1.47536357 |
48 | MP0003329_amyloid_beta_deposits | 1.45558613 |
49 | MP0004381_abnormal_hair_follicle | 1.44536007 |
50 | MP0003806_abnormal_nucleotide_metabolis | 1.44435792 |
51 | MP0002909_abnormal_adrenal_gland | 1.43343340 |
52 | MP0002998_abnormal_bone_remodeling | 1.39451721 |
53 | MP0003075_altered_response_to | 1.37073888 |
54 | MP0003690_abnormal_glial_cell | 1.36255050 |
55 | * MP0000920_abnormal_myelination | 1.32697469 |
56 | MP0004270_analgesia | 1.31351882 |
57 | MP0001440_abnormal_grooming_behavior | 1.31058610 |
58 | MP0005636_abnormal_mineral_homeostasis | 1.31023999 |
59 | MP0002118_abnormal_lipid_homeostasis | 1.28518017 |
60 | MP0002168_other_aberrant_phenotype | 1.28053484 |
61 | MP0009643_abnormal_urine_homeostasis | 1.28046931 |
62 | MP0003724_increased_susceptibility_to | 1.27513187 |
63 | MP0001533_abnormal_skeleton_physiology | 1.25269468 |
64 | MP0009745_abnormal_behavioral_response | 1.22633576 |
65 | MP0004742_abnormal_vestibular_system | 1.21208007 |
66 | MP0009764_decreased_sensitivity_to | 1.20209915 |
67 | MP0005164_abnormal_response_to | 1.19546373 |
68 | MP0001764_abnormal_homeostasis | 1.19453814 |
69 | MP0003868_abnormal_feces_composition | 1.18339017 |
70 | MP0004510_myositis | 1.18322805 |
71 | MP0002837_dystrophic_cardiac_calcinosis | 1.18229464 |
72 | * MP0002064_seizures | 1.17307384 |
73 | MP0005275_abnormal_skin_tensile | 1.16561630 |
74 | MP0003183_abnormal_peptide_metabolism | 1.16509171 |
75 | MP0001905_abnormal_dopamine_level | 1.15759776 |
76 | MP0004043_abnormal_pH_regulation | 1.14322485 |
77 | MP0003303_peritoneal_inflammation | 1.13118004 |
78 | MP0001486_abnormal_startle_reflex | 1.11361286 |
79 | MP0001765_abnormal_ion_homeostasis | 1.10776666 |
80 | MP0002148_abnormal_hypersensitivity_rea | 1.10438928 |
81 | MP0010352_gastrointestinal_tract_polyps | 1.10186827 |
82 | MP0000538_abnormal_urinary_bladder | 1.09934139 |
83 | MP0009785_altered_susceptibility_to | 1.08550300 |
84 | MP0005023_abnormal_wound_healing | 1.07803813 |
85 | MP0000013_abnormal_adipose_tissue | 1.06751500 |
86 | MP0000569_abnormal_digit_pigmentation | 1.06657531 |
87 | MP0005646_abnormal_pituitary_gland | 1.06381274 |
88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02823243 |
89 | * MP0002572_abnormal_emotion/affect_behav | 1.02108942 |
90 | MP0001501_abnormal_sleep_pattern | 1.02036009 |
91 | MP0003091_abnormal_cell_migration | 1.01025751 |
92 | MP0003186_abnormal_redox_activity | 1.00701130 |
93 | MP0002272_abnormal_nervous_system | 1.00132044 |
94 | MP0003795_abnormal_bone_structure | 0.99513703 |
95 | MP0005535_abnormal_body_temperature | 0.99406052 |
96 | MP0010368_abnormal_lymphatic_system | 0.97579108 |
97 | MP0005409_darkened_coat_color | 0.96416229 |
98 | MP0002734_abnormal_mechanical_nocicepti | 0.96401860 |
99 | MP0000015_abnormal_ear_pigmentation | 0.96111225 |
100 | MP0005390_skeleton_phenotype | 0.95483401 |
101 | MP0005408_hypopigmentation | 0.95079357 |
102 | MP0009780_abnormal_chondrocyte_physiolo | 0.94437337 |
103 | MP0005508_abnormal_skeleton_morphology | 0.92664628 |
104 | MP0000858_altered_metastatic_potential | 0.92072786 |
105 | MP0005379_endocrine/exocrine_gland_phen | 0.91579133 |
106 | MP0005166_decreased_susceptibility_to | 0.89763619 |
107 | MP0005167_abnormal_blood-brain_barrier | 0.89435293 |
108 | MP0003448_altered_tumor_morphology | 0.87640074 |
109 | MP0000767_abnormal_smooth_muscle | 0.87197994 |
110 | MP0001188_hyperpigmentation | 0.85422518 |
111 | MP0002067_abnormal_sensory_capabilities | 0.85101894 |
112 | MP0003436_decreased_susceptibility_to | 0.84672892 |
113 | MP0000609_abnormal_liver_physiology | 0.84180839 |
114 | MP0005319_abnormal_enzyme/_coenzyme | 0.83532791 |
115 | MP0009046_muscle_twitch | 0.82649332 |
116 | MP0001970_abnormal_pain_threshold | 0.81967320 |
117 | MP0002733_abnormal_thermal_nociception | 0.81484416 |
118 | MP0005395_other_phenotype | 0.81208472 |
119 | MP0002090_abnormal_vision | 0.80777296 |
120 | MP0000249_abnormal_blood_vessel | 0.80135048 |
121 | MP0008469_abnormal_protein_level | 0.79718536 |
122 | MP0006082_CNS_inflammation | 0.79611270 |
123 | MP0002136_abnormal_kidney_physiology | 0.79264059 |
124 | MP0003635_abnormal_synaptic_transmissio | 0.79047233 |
125 | MP0001243_abnormal_dermal_layer | 0.78637461 |
126 | MP0004142_abnormal_muscle_tone | 0.77566772 |
127 | MP0003172_abnormal_lysosome_physiology | 0.77454686 |
128 | MP0001756_abnormal_urination | 0.77249871 |
129 | MP0005171_absent_coat_pigmentation | 0.76853925 |
130 | MP0003136_yellow_coat_color | 0.76040633 |
131 | MP0002971_abnormal_brown_adipose | 0.75083399 |
132 | MP0001984_abnormal_olfaction | 0.75037497 |
133 | MP0005595_abnormal_vascular_smooth | 0.75015863 |
134 | MP0010234_abnormal_vibrissa_follicle | 0.74043620 |
135 | MP0004782_abnormal_surfactant_physiolog | 0.73736122 |
136 | MP0001845_abnormal_inflammatory_respons | 0.73555271 |
137 | * MP0001963_abnormal_hearing_physiology | 0.73029387 |
138 | MP0002419_abnormal_innate_immunity | 0.72084043 |
139 | * MP0002063_abnormal_learning/memory/cond | 0.71304860 |
140 | MP0000371_diluted_coat_color | 0.70603602 |
141 | MP0000230_abnormal_systemic_arterial | 0.70548016 |
142 | MP0008260_abnormal_autophagy | 0.70314341 |
143 | MP0008874_decreased_physiological_sensi | 0.70178176 |
144 | MP0005647_abnormal_sex_gland | 0.69958505 |
145 | MP0002295_abnormal_pulmonary_circulatio | 0.69760965 |
146 | MP0002229_neurodegeneration | 0.69292372 |
147 | MP0003045_fibrosis | 0.68675723 |
148 | MP0005423_abnormal_somatic_nervous | 0.68120535 |
149 | MP0001529_abnormal_vocalization | 0.67994060 |
150 | MP0005503_abnormal_tendon_morphology | 0.67465640 |
151 | MP0001986_abnormal_taste_sensitivity | 0.66825237 |
152 | MP0009642_abnormal_blood_homeostasis | 0.66450676 |
153 | MP0001661_extended_life_span | 0.66316246 |
154 | MP0000026_abnormal_inner_ear | 0.66198367 |
155 | MP0003828_pulmonary_edema | 0.66167331 |
156 | MP0004484_altered_response_of | 0.65752930 |
157 | MP0003879_abnormal_hair_cell | 0.65216723 |
158 | MP0001542_abnormal_bone_strength | 0.64989059 |
159 | * MP0003633_abnormal_nervous_system | 0.64663169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperphosphatemia (HP:0002905) | 5.36919098 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.72443507 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 4.38604611 |
4 | Dysostosis multiplex (HP:0000943) | 4.32256361 |
5 | Premature rupture of membranes (HP:0001788) | 3.95781111 |
6 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.93908860 |
7 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.93908860 |
8 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.93908860 |
9 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.82150538 |
10 | Mucopolysacchariduria (HP:0008155) | 3.82150538 |
11 | Intrahepatic cholestasis (HP:0001406) | 3.68137436 |
12 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.47047803 |
13 | Xanthomatosis (HP:0000991) | 3.42329256 |
14 | Joint hemorrhage (HP:0005261) | 3.33499775 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.25175178 |
16 | Loss of speech (HP:0002371) | 3.23346185 |
17 | Deep venous thrombosis (HP:0002625) | 3.22377669 |
18 | * Conjugated hyperbilirubinemia (HP:0002908) | 3.18823481 |
19 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.17193105 |
20 | Increased cerebral lipofuscin (HP:0011813) | 3.14209568 |
21 | Hyperventilation (HP:0002883) | 3.08606492 |
22 | Neurofibrillary tangles (HP:0002185) | 3.07886594 |
23 | Systemic lupus erythematosus (HP:0002725) | 3.07407860 |
24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.02585168 |
25 | Complement deficiency (HP:0004431) | 2.96323359 |
26 | Fat malabsorption (HP:0002630) | 2.93055086 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.90038540 |
28 | Myocardial infarction (HP:0001658) | 2.88143137 |
29 | Hypomagnesemia (HP:0002917) | 2.87468360 |
30 | Renal Fanconi syndrome (HP:0001994) | 2.86876164 |
31 | Progressive neurologic deterioration (HP:0002344) | 2.81290802 |
32 | Increased circulating renin level (HP:0000848) | 2.77641630 |
33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76617101 |
34 | Parakeratosis (HP:0001036) | 2.71083779 |
35 | Abnormality of renal resorption (HP:0011038) | 2.70503226 |
36 | Tetraparesis (HP:0002273) | 2.69324071 |
37 | Metabolic alkalosis (HP:0200114) | 2.68302718 |
38 | Vertebral compression fractures (HP:0002953) | 2.67502100 |
39 | Nuclear cataract (HP:0100018) | 2.65868279 |
40 | Glycosuria (HP:0003076) | 2.65798873 |
41 | Abnormality of urine glucose concentration (HP:0011016) | 2.65798873 |
42 | Prolonged neonatal jaundice (HP:0006579) | 2.64436336 |
43 | Steatorrhea (HP:0002570) | 2.60155543 |
44 | Mitral stenosis (HP:0001718) | 2.58168877 |
45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55833350 |
46 | Hyperglycinemia (HP:0002154) | 2.54626700 |
47 | * Metaphyseal irregularity (HP:0003025) | 2.53961949 |
48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.53201445 |
49 | Abnormality of macrophages (HP:0004311) | 2.53095287 |
50 | Alkalosis (HP:0001948) | 2.51696870 |
51 | Protrusio acetabuli (HP:0003179) | 2.48965252 |
52 | Abnormality of glycine metabolism (HP:0010895) | 2.47359105 |
53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47359105 |
54 | Ketosis (HP:0001946) | 2.46915304 |
55 | Abnormality of proline metabolism (HP:0010907) | 2.46820115 |
56 | Hydroxyprolinuria (HP:0003080) | 2.46820115 |
57 | Hyperglycinuria (HP:0003108) | 2.46408565 |
58 | Cerebral edema (HP:0002181) | 2.44859968 |
59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.43255147 |
60 | Abnormality of methionine metabolism (HP:0010901) | 2.43108934 |
61 | Acute encephalopathy (HP:0006846) | 2.42925628 |
62 | Epidermoid cyst (HP:0200040) | 2.41944846 |
63 | * Vacuolated lymphocytes (HP:0001922) | 2.41906013 |
64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.38200275 |
65 | Hypokalemic alkalosis (HP:0001949) | 2.37014718 |
66 | Vascular tortuosity (HP:0004948) | 2.37000586 |
67 | Hypobetalipoproteinemia (HP:0003563) | 2.35927344 |
68 | Cerebral inclusion bodies (HP:0100314) | 2.34660485 |
69 | Amyloidosis (HP:0011034) | 2.33891414 |
70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.33512808 |
71 | Aortic dissection (HP:0002647) | 2.31523059 |
72 | Zonular cataract (HP:0010920) | 2.29430550 |
73 | Follicular hyperkeratosis (HP:0007502) | 2.28379582 |
74 | Hematochezia (HP:0002573) | 2.28175032 |
75 | Petechiae (HP:0000967) | 2.26576716 |
76 | Proximal tubulopathy (HP:0000114) | 2.26465838 |
77 | Purpura (HP:0000979) | 2.25880299 |
78 | Hyperammonemia (HP:0001987) | 2.25419162 |
79 | Disinhibition (HP:0000734) | 2.22320629 |
80 | Vascular calcification (HP:0004934) | 2.21467449 |
81 | Gout (HP:0001997) | 2.21437997 |
82 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21164241 |
83 | Enlarged kidneys (HP:0000105) | 2.20791144 |
84 | Renal tubular dysfunction (HP:0000124) | 2.16635765 |
85 | Abnormality of purine metabolism (HP:0004352) | 2.15938349 |
86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.15154534 |
87 | Abnormality of magnesium homeostasis (HP:0004921) | 2.14408110 |
88 | Acute necrotizing encephalopathy (HP:0006965) | 2.14104981 |
89 | Arterial tortuosity (HP:0005116) | 2.13765864 |
90 | Glomerulonephritis (HP:0000099) | 2.12635090 |
91 | Hypophosphatemic rickets (HP:0004912) | 2.11318335 |
92 | Tongue fasciculations (HP:0001308) | 2.11289261 |
93 | Asymmetric septal hypertrophy (HP:0001670) | 2.10360228 |
94 | Hyperphosphaturia (HP:0003109) | 2.10298927 |
95 | Ovoid vertebral bodies (HP:0003300) | 2.09802402 |
96 | Delayed CNS myelination (HP:0002188) | 2.09608244 |
97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09432231 |
98 | Osteolytic defects of the hand bones (HP:0009699) | 2.09432231 |
99 | Increased CSF protein (HP:0002922) | 2.08207410 |
100 | Tubulointerstitial nephritis (HP:0001970) | 2.07837516 |
101 | Protuberant abdomen (HP:0001538) | 2.06902668 |
102 | Confusion (HP:0001289) | 2.06125594 |
103 | Lethargy (HP:0001254) | 2.04502859 |
104 | Hypokinesia (HP:0002375) | 2.03308686 |
105 | Metabolic acidosis (HP:0001942) | 2.03043548 |
106 | Albinism (HP:0001022) | 2.02974312 |
107 | Abnormality of complement system (HP:0005339) | 2.02650164 |
108 | Recurrent corneal erosions (HP:0000495) | 2.02320059 |
109 | Opisthotonus (HP:0002179) | 2.01538098 |
110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.01503968 |
111 | Ketoacidosis (HP:0001993) | 2.00043034 |
112 | Hyperparathyroidism (HP:0000843) | 1.99797140 |
113 | Renal tubular acidosis (HP:0001947) | 1.99541676 |
114 | Vomiting (HP:0002013) | 1.99415068 |
115 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99350417 |
116 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98761327 |
117 | Mutism (HP:0002300) | 1.98414629 |
118 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98168778 |
119 | Methylmalonic acidemia (HP:0002912) | 1.97950064 |
120 | Increased hepatocellular lipid droplets (HP:0006565) | 1.96887522 |
121 | Hypophosphatemia (HP:0002148) | 1.96583415 |
122 | Hypocalcemia (HP:0002901) | 1.96175225 |
123 | Cervical subluxation (HP:0003308) | 1.95862073 |
124 | Abnormal urine phosphate concentration (HP:0012599) | 1.95842471 |
125 | Progressive macrocephaly (HP:0004481) | 1.95381213 |
126 | Skin nodule (HP:0200036) | 1.95380957 |
127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94707523 |
128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94707523 |
129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94707523 |
130 | * Cardiomegaly (HP:0001640) | 1.94520299 |
131 | Mitochondrial inheritance (HP:0001427) | 1.93042386 |
132 | Abnormality of renal excretion (HP:0011036) | 1.92924072 |
133 | Abnormal urine output (HP:0012590) | 1.92630642 |
134 | Conjunctival telangiectasia (HP:0000524) | 1.91769886 |
135 | Dicarboxylic aciduria (HP:0003215) | 1.90461806 |
136 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.90461806 |
137 | Hypoglycemic coma (HP:0001325) | 1.89657677 |
138 | Hypothermia (HP:0002045) | 1.89552612 |
139 | Polyuria (HP:0000103) | 1.89315070 |
140 | Tetany (HP:0001281) | 1.88788165 |
141 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.88656616 |
142 | Cardiovascular calcification (HP:0011915) | 1.86701038 |
143 | White forelock (HP:0002211) | 1.85382947 |
144 | Conical tooth (HP:0000698) | 1.85300662 |
145 | Soft skin (HP:0000977) | 1.84745464 |
146 | Hypoglycemic seizures (HP:0002173) | 1.84519943 |
147 | Axonal loss (HP:0003447) | 1.84341133 |
148 | Thickened helices (HP:0000391) | 1.84338289 |
149 | Cerebral hemorrhage (HP:0001342) | 1.83349952 |
150 | * Fair hair (HP:0002286) | 1.82946244 |
151 | Abnormality of the axillary hair (HP:0100134) | 1.81432691 |
152 | Abnormality of secondary sexual hair (HP:0009888) | 1.81432691 |
153 | Spondylolisthesis (HP:0003302) | 1.81108175 |
154 | Ankle contracture (HP:0006466) | 1.80410335 |
155 | Diminished motivation (HP:0000745) | 1.79531657 |
156 | Retinal atrophy (HP:0001105) | 1.78839133 |
157 | Muscle fibrillation (HP:0010546) | 1.78531361 |
158 | Joint stiffness (HP:0001387) | 1.78407627 |
159 | Abnormal drinking behavior (HP:0030082) | 1.77250693 |
160 | Polydipsia (HP:0001959) | 1.77250693 |
161 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77014959 |
162 | Gingival bleeding (HP:0000225) | 1.76676670 |
163 | Basal ganglia calcification (HP:0002135) | 1.76007036 |
164 | Rickets (HP:0002748) | 1.72443050 |
165 | Abnormality of renin-angiotensin system (HP:0000847) | 1.69250627 |
166 | Apathy (HP:0000741) | 1.68462860 |
167 | Malnutrition (HP:0004395) | 1.68355787 |
168 | Aortic aneurysm (HP:0004942) | 1.65055650 |
169 | Increased serum ferritin (HP:0003281) | 1.63207536 |
170 | Blue sclerae (HP:0000592) | 1.60687932 |
171 | Wormian bones (HP:0002645) | 1.59439173 |
172 | Upper motor neuron abnormality (HP:0002127) | 1.59248655 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK16 | 3.89514434 |
2 | CASK | 3.11965251 |
3 | OXSR1 | 3.06088757 |
4 | MAP3K3 | 2.99022716 |
5 | PDK2 | 2.94582693 |
6 | TESK1 | 2.68785864 |
7 | LIMK1 | 2.65093502 |
8 | INSRR | 2.64246538 |
9 | STK39 | 2.35867984 |
10 | EPHA4 | 2.35017647 |
11 | BMPR1B | 2.33971008 |
12 | TIE1 | 2.13934546 |
13 | DDR2 | 2.12020476 |
14 | GRK5 | 1.95307292 |
15 | IRAK3 | 1.91727346 |
16 | MAP3K14 | 1.87797445 |
17 | RIPK4 | 1.86969933 |
18 | WNK4 | 1.84839412 |
19 | TNIK | 1.84147101 |
20 | EPHA2 | 1.82032941 |
21 | BMPR2 | 1.71436603 |
22 | EPHB2 | 1.68572212 |
23 | PAK4 | 1.66563014 |
24 | BCR | 1.64861989 |
25 | IRAK2 | 1.63535559 |
26 | GRK7 | 1.55055033 |
27 | MAP4K2 | 1.54252767 |
28 | PBK | 1.53399343 |
29 | ACVR1B | 1.53084451 |
30 | ERN1 | 1.50330651 |
31 | WNK3 | 1.49243244 |
32 | IRAK4 | 1.47087476 |
33 | ARAF | 1.46190907 |
34 | NTRK3 | 1.44100540 |
35 | STK38L | 1.43206116 |
36 | PRKG2 | 1.41488332 |
37 | RIPK1 | 1.40474545 |
38 | TRPM7 | 1.36851746 |
39 | MAP3K12 | 1.35363556 |
40 | PTK2 | 1.34410143 |
41 | BCKDK | 1.31892064 |
42 | IRAK1 | 1.28508073 |
43 | MAP2K7 | 1.27763472 |
44 | MAP3K13 | 1.26564211 |
45 | TAOK3 | 1.26542486 |
46 | STK38 | 1.26371416 |
47 | PLK2 | 1.22904085 |
48 | NUAK1 | 1.22673695 |
49 | FGR | 1.22317738 |
50 | LMTK2 | 1.20655796 |
51 | PINK1 | 1.19683219 |
52 | MAP3K5 | 1.18711511 |
53 | TXK | 1.18121277 |
54 | PIK3CG | 1.14602285 |
55 | TBK1 | 1.13881160 |
56 | PRKCE | 1.11743840 |
57 | NME1 | 1.11468150 |
58 | MST1R | 1.10639169 |
59 | CAMK2B | 1.09457489 |
60 | PTK2B | 1.09075488 |
61 | AKT3 | 1.08861694 |
62 | MAPKAPK3 | 1.07440614 |
63 | PKN1 | 1.05789466 |
64 | EPHB1 | 1.05692622 |
65 | GRK1 | 1.02632610 |
66 | MOS | 0.99352770 |
67 | BLK | 0.99055023 |
68 | GSK3A | 0.98269481 |
69 | SGK494 | 0.97268739 |
70 | SGK223 | 0.97268739 |
71 | ZAP70 | 0.94861650 |
72 | MAP3K2 | 0.92156686 |
73 | ERBB4 | 0.89804273 |
74 | TAOK1 | 0.89428657 |
75 | MST4 | 0.89397562 |
76 | PDGFRA | 0.89154463 |
77 | NTRK1 | 0.88102540 |
78 | CAMK2A | 0.87295223 |
79 | DAPK3 | 0.86414395 |
80 | MUSK | 0.86337444 |
81 | PRKCQ | 0.86114673 |
82 | ADRBK2 | 0.84523816 |
83 | MAP2K4 | 0.82610653 |
84 | DAPK2 | 0.82415577 |
85 | MET | 0.80224490 |
86 | SIK3 | 0.79724894 |
87 | CAMK2D | 0.77859429 |
88 | MAPK15 | 0.77417645 |
89 | BRAF | 0.76510683 |
90 | ABL2 | 0.76300275 |
91 | NEK6 | 0.74049087 |
92 | MAPK7 | 0.73515963 |
93 | MAPK13 | 0.72647385 |
94 | TRIM28 | 0.71975946 |
95 | FRK | 0.71565443 |
96 | FES | 0.70478850 |
97 | EIF2AK3 | 0.70423504 |
98 | MAPKAPK5 | 0.68501493 |
99 | CAMK2G | 0.68205214 |
100 | LATS2 | 0.67860338 |
101 | MAP2K6 | 0.66884562 |
102 | NEK9 | 0.66761386 |
103 | PRKCG | 0.65946513 |
104 | CSNK1G3 | 0.65334144 |
105 | SGK2 | 0.62489366 |
106 | TESK2 | 0.62182936 |
107 | CDC42BPA | 0.61903409 |
108 | NME2 | 0.61263939 |
109 | CSNK1G1 | 0.61073269 |
110 | EPHA3 | 0.60870145 |
111 | MAP3K4 | 0.60507777 |
112 | CSNK1A1L | 0.60253957 |
113 | GRK6 | 0.57624276 |
114 | MAP3K6 | 0.56628286 |
115 | PIM2 | 0.56213182 |
116 | FGFR2 | 0.55871775 |
117 | STK3 | 0.55589675 |
118 | PRKAA2 | 0.54869596 |
119 | ROCK1 | 0.54161265 |
120 | MYLK | 0.53902600 |
121 | ERBB3 | 0.53877698 |
122 | PDPK1 | 0.53825309 |
123 | TAOK2 | 0.52922856 |
124 | PHKG2 | 0.52087360 |
125 | PHKG1 | 0.52087360 |
126 | IKBKE | 0.51437890 |
127 | PAK2 | 0.51043554 |
128 | FLT3 | 0.50994394 |
129 | CSF1R | 0.49789618 |
130 | TGFBR2 | 0.49570937 |
131 | TYK2 | 0.49450578 |
132 | NEK1 | 0.48009894 |
133 | CSNK1G2 | 0.47900138 |
134 | MAPK12 | 0.47727837 |
135 | ROCK2 | 0.47446059 |
136 | PRKACA | 0.47291917 |
137 | ZAK | 0.47087015 |
138 | FGFR4 | 0.46947478 |
139 | EIF2AK2 | 0.46924109 |
140 | CDK3 | 0.46211943 |
141 | PDGFRB | 0.46169057 |
142 | MAP3K1 | 0.45411043 |
143 | JAK1 | 0.45021095 |
144 | PRKCZ | 0.44764645 |
145 | BMX | 0.44399697 |
146 | IGF1R | 0.43789934 |
147 | LATS1 | 0.43345463 |
148 | ADRBK1 | 0.42479166 |
149 | PRKCA | 0.42322716 |
150 | YES1 | 0.42120601 |
151 | CAMKK2 | 0.40966968 |
152 | MATK | 0.40921844 |
153 | FER | 0.40262429 |
154 | PRKG1 | 0.38027719 |
155 | PAK3 | 0.36865820 |
156 | PRKCD | 0.36731522 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08687746 |
2 | Histidine metabolism_Homo sapiens_hsa00340 | 2.45789734 |
3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43972005 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35864103 |
5 | Peroxisome_Homo sapiens_hsa04146 | 2.31432239 |
6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18977804 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18699505 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16949645 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16457014 |
10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.15692238 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09921138 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06006608 |
13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.05723118 |
14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.01789930 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00778655 |
16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92914313 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.84838473 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83125337 |
19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.82057561 |
20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80829755 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.78141658 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77893375 |
23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73987421 |
24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70064691 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65856098 |
26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64224328 |
27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62354262 |
28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.60558067 |
29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58536281 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57449107 |
31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54197029 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52760404 |
33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50551494 |
34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42354591 |
35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42046899 |
36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34528418 |
37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29577530 |
38 | Protein export_Homo sapiens_hsa03060 | 1.25489653 |
39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21946750 |
40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21456627 |
41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21088878 |
42 | Bile secretion_Homo sapiens_hsa04976 | 1.19365718 |
43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19127489 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17071466 |
45 | Pertussis_Homo sapiens_hsa05133 | 1.15181116 |
46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14257361 |
47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.11003883 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10645462 |
49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09778639 |
50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09726994 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09107717 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06691424 |
53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04970933 |
54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00917475 |
55 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99837798 |
56 | ABC transporters_Homo sapiens_hsa02010 | 0.97216718 |
57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96517604 |
58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96375067 |
59 | Salmonella infection_Homo sapiens_hsa05132 | 0.95913841 |
60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94129271 |
61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92251608 |
62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91645620 |
63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90935614 |
64 | * Lysosome_Homo sapiens_hsa04142 | 0.88711278 |
65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88110892 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85978986 |
67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85005684 |
68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83743873 |
69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82057897 |
70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80427994 |
71 | Malaria_Homo sapiens_hsa05144 | 0.79785407 |
72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79454153 |
73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78142343 |
74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78028269 |
75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78024562 |
76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78014089 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.77611621 |
78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75434484 |
79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74597638 |
80 | Phagosome_Homo sapiens_hsa04145 | 0.72145529 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71791064 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71219355 |
83 | Tuberculosis_Homo sapiens_hsa05152 | 0.70220576 |
84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69976711 |
85 | Legionellosis_Homo sapiens_hsa05134 | 0.69962757 |
86 | Focal adhesion_Homo sapiens_hsa04510 | 0.69277862 |
87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69175215 |
88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68944871 |
89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67204711 |
90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66600375 |
91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65443172 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64686115 |
93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63708027 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63003226 |
95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60959523 |
96 | Shigellosis_Homo sapiens_hsa05131 | 0.60558525 |
97 | Taste transduction_Homo sapiens_hsa04742 | 0.59620858 |
98 | Bladder cancer_Homo sapiens_hsa05219 | 0.59442151 |
99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58571687 |
100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58392776 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56639713 |
102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56306513 |
103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55815983 |
104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55489627 |
105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54660140 |
106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54323245 |
107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53785239 |
108 | Mineral absorption_Homo sapiens_hsa04978 | 0.50678027 |
109 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50492876 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49727942 |
111 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48461380 |
112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46551959 |
113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46255023 |
114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45161473 |
115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44796402 |
116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43149476 |
117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43137719 |
118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42708602 |
119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.42704879 |
120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42541228 |
121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42083931 |
122 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41928849 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41019258 |
124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40654839 |
125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40180409 |
126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40047148 |
127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38249590 |
128 | Endocytosis_Homo sapiens_hsa04144 | 0.37854160 |
129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37238613 |
130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35838512 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35110299 |
132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34271830 |
133 | Salivary secretion_Homo sapiens_hsa04970 | 0.34017389 |
134 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32964737 |
135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32803011 |
136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32768135 |
137 | Hepatitis C_Homo sapiens_hsa05160 | 0.32730017 |
138 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32720181 |
139 | Platelet activation_Homo sapiens_hsa04611 | 0.32035008 |
140 | Prion diseases_Homo sapiens_hsa05020 | 0.31559098 |
141 | Morphine addiction_Homo sapiens_hsa05032 | 0.31128390 |
142 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30337898 |
143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25609519 |